The Manila Times

Quantum Reports Strengthened Liquidity, Reduced Cash Burn, and Disciplined Cost Management in First Quarter 2026

Application Filed to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis ...

MS-hit Eric credits medical cannabis for 'saving' his life

Cannabis has been legalised for medial use since 2018 ...

First Tracks: Huge Cash Reserves Will Not Sustain Testing For Long

First Tracks Biotherapeutics, spun off from AnaptysBio, launches with $180M cash and a diverse, early-stage pipeline. Read ...

Man in four comas since falling off a slide at 13 says cannabis has saved him

Eric Powers was left with complex neurological problems ...
Neurology Advisor

FDA Grants Fast Track Designation to Tazbentetol for ALS Treatment

The FDA has granted Fast Track designation to tazbentetol for the treatment of amyotrophic lateral sclerosis (ALS).
The Manila Times

World's First | Mabwell's 9MW5211 Receives FDA Clearance for Clinical Trial Application

Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the Investigational New Drug (IND) application for 9MW5211, its ...

'I've been in four comas since falling off a slide at 13 but cannabis saved me'

Eric Powers was repeatedly hospitalised until he started using the drug ...

In a Milestone for A.L.S., a Treatment Helps Some Patients Improve

The drug is for a small subset of patients. But evidence that breathing and strength can get better for some of them is ...

'I tried medical cannabis for the first time - it was like a switch went off'

Eric Powers, 49, suffered a freak accident when he was a child which has affected his health throughout his life ...

Specialized RNA molecules could counter ALS neurodegeneration

Misshapen proteins cause a mess of trouble—particularly in neurodegenerative diseases. But a new study suggests it's possible ...

Quoin Pharmaceuticals, Inc.: Quoin Pharmaceuticals Provides Corporate Update and Reports First Quarter 2026 Financial Results

Filed Breakthrough Medicine Designation Application with Saudi FDA for QRX003 in Netherton Syndrome - Submitted Application to Japanese MHLW for Orphan Drug Designation (ODD) for QRX003; MHLW Confirme ...
Healio

Increased risk for urinary tract infections, urosepsis linked with MS medications

Several disease-modifying therapies for MS were associated with increased risks for urinary tract infections and urosepsis, ...